Showing results (161-170 of 228) with videos related to
Sort By:
Pageof 23
International Journal of Hematology|April 16, 2022
Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantationJin Hayakawa, Hideki Nakasone, Daisuke Minakata, et al.Experimental Hematology|January 11, 2014
Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblastsHideki Nakasone, Kiriko Terasako-Saito, Rie Yamazaki, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 26, 2020
Association between the kinetics of cytomegalovirus reactivation evaluated in terms of the area under the curve of cytomegalovirus antigenemia and invasive mold infection during the post-engraftment phase after allogeneic hematopoietic stem cell transplantationShun-Ichi Kimura, Junko Takeshita, Masakatsu Kawamura, et al.The Lancet Regional Health. Western Pacific|December 18, 2023
Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national surveyNobuaki Nakano, Hideki Nakasone, Shigeo Fuji, et al.Scientific Reports|July 20, 2026
Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysisSatoshi Yamasaki, Masamitsu Yanada, Tomomi Toubai, et al.International Journal of Hematology|August 11, 2021
Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitorsKazuki Yoshimura, Shun-Ichi Kimura, Masakatsu Kawamura, et al.Annals of Hematology|September 23, 2015
Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALLShinichi Kako, Yu Akahoshi, Naonori Harada, et al.Bone Marrow Transplantation|September 2, 2018
Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantationKazuaki Kameda, Shun-Ichi Kimura, Yukiko Misaki, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 13, 2020
Impact of neutropenia evaluated in terms of the D-index on invasive fungal disease while on empiric or preemptive antifungal treatment strategy in the early phase after allogeneic hematopoietic stem cell transplantationShun-Ichi Kimura, Yuhei Nakamura, Masakatsu Kawamura, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 25, 2020
Impact of the patient's body weight on the efficacy and adverse events of valganciclovir for cytomegalovirus reactivation after hematopoietic stem cell transplantationYukiko Misaki, Shun-Ichi Kimura, Masakatsu Kawamura, et al.Pageof 23